Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin vs mitomycin with esophageal dilation for refractory esophageal stricture after esophageal atresia repair in children
ChiCTR2200058445Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bleomycin and mitomycin c in Esophageal stricture (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Effectiveness of treatment. Started Nov 2021; status: recruiting.
02
Drugs
bleomycinmitomycin c
03
Conditions
Esophageal stricture
Beyond the preview
Go deeper on ChiCTR2200058445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058445.